Security
NANO-X IMAGING LTD Ordinary Shares · NNOX
NNOXNASDAQCommon stockCurrentCIK 1795251Updated Oct 30, 2026
NNOX price & chart
Loading TradingView…
NASDAQ:NNOX on TradingView ↗About the company
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.
In the news
Portnoy Law Firm Announces Class Action on Behalf of Nano-X Imaging Ltd. Investors ↗
Pomerantz Law Firm Announces the Filing of a Class Action Against Nano-X Imaging Ltd. and Certain Officers - NNOX ↗
Pomerantz Law Firm Announces the Filing of a Class Action Against Nano-X Imaging Ltd. and Certain Officers - NNOX ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 162,165,000Source | 210,002,000Source | 218,648,000Source | 253,933,000Source |
| Property, Plant and Equipment, NetUSD | 29,677,000Source | 45,355,000Source | 42,343,000Source | 43,545,000Source |
| GoodwillUSD | 316,000Source | — | — | 7,420,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | 80,607,000Source | 91,219,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 49,151,000Source | 39,304,000Source | 56,377,000Source | 38,463,000Source |
| Accounts Receivable | —Source | —Source | —Source | — |
| Inventory, NetUSD | 3,070,000Source | 1,493,000Source | 2,356,000Source | — |
| Assets, CurrentUSD | 66,793,000Source | 78,680,000Source | 88,635,000Source | 82,461,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,518,000Source | 3,843,000Source | 4,573,000Source | 1,157,000Source |
| Other Assets, NoncurrentUSD | 1,632,000Source | 1,792,000Source | 2,163,000Source | 2,867,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 22,433,000Source | 20,883,000Source | 23,134,000Source | 37,253,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 198,000Source | 181,000Source | 165,000Source | 158,000Source |
| Additional Paid in CapitalUSD | — | — | 515,887,000Source | 477,953,000Source |
| Retained Earnings (Accumulated Deficit)USD | -448,767,000Source | -373,749,000Source | -320,233,000Source | -259,457,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | -1,000Source | -305,000Source | -1,974,000Source |
| Stockholders' Equity Attributable to ParentUSD | 139,732,000Source | 189,119,000Source | 195,514,000Source | 216,680,000Source |
| Additional Paid in Capital, Common StockUSD | 588,301,000Source | 562,688,000Source | — | — |
| Liabilities and EquityUSD | 162,165,000Source | 210,002,000Source | 218,648,000Source | 253,933,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 16,888,000Source | 13,972,000Source | 15,524,000Source | 25,074,000Source |
| Operating Lease, Liability, CurrentUSD | 950,000Source | 745,000Source | 861,000Source | 740,000Source |
| Accounts Payable, CurrentUSD | 2,886,000Source | 2,209,000Source | 3,303,000Source | 3,619,000Source |
| Operating Lease, Liability, NoncurrentUSD | 3,765,000Source | 3,640,000Source | 4,045,000Source | 398,000Source |
| Deferred Income Tax Liabilities, NetUSD | 600,000Source | 2,576,000Source | 2,953,000Source | 3,330,000Source |
| Other Liabilities, NoncurrentUSD | 990,000Source | 695,000Source | 612,000Source | 483,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 4,224,000Source | 3,968,000Source | 3,920,000Source | 12,240,000Source |
| Deferred Revenue, CurrentUSD | — | — | 543,000Source | 182,000Source |
| Deferred Revenue, NoncurrentUSD | — | — | — | 398,000Source |
| Long-term Debt, Current MaturitiesUSD | — | 3,061,000Source | 3,490,000Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -113,243,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 4,190,000Source | 7,261,000Source | 6,838,000Source | 18,623,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 325,000Source | 277,000Source | — | — |
| Deferred Income Tax Expense (Benefit)USD | -1,976,000Source | -377,000Source | -377,000Source | -3,733,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -40,793,000Source | -36,598,000Source | -44,777,000Source | -43,385,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 200,000Source | — | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 29,373,000Source | -20,051,000Source | 35,433,000Source | 14,606,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 4,207,000Source | 2,767,000Source | 3,303,000Source | 7,171,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 21,368,000Source | 39,504,000Source | 27,252,000Source | 804,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 9,847,000Source | -17,073,000Source | 17,848,000Source | -28,243,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 184,000Source | 53,000Source | 3,000Source | 147,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -101,000Source | 72,000Source | -60,000Source | -268,000Source |
| Additional Financial Items | ||||
| AmortizationUSD | 10,508,000Source | 10,612,000Source | — | — |
| Share-based Payment Arrangement, ExpenseUSD | 6,028,000Source | 9,602,000Source | 15,721,000Source | 17,061Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | 10,607,000Source |
| Amortization of Intangible AssetsUSD | 10,508,000Source | 10,612,000Source | 10,612,000Source | 10,607,000Source |
| DepreciationUSD | 1,189,000Source | 1,121,000Source | 1,198,000Source | 905,000Source |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | — | — | -178,000Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -153,000Source | 512,000Source | -69,000Source | — |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | -172,000Source |
| Gain (Loss) on InvestmentsUSD | — | 2,000Source | -178,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -207,000Source | -202,000Source | -1,297,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | 47,000Source |
| General and Administrative ExpenseUSD | 21,587,000Source | 22,455,000Source | 24,272,000Source | 41,254,000Source |
| GoodwillUSD | 316,000Source | — | — | 7,420,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | 50,878,000Source |
| Goodwill, Impairment LossUSD | — | — | 7,420,000Source | 50,878,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | 50,878,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -61,115,000Source | — |
| Income Tax Expense (Benefit)USD | -1,792,000Source | -358,000Source | -339,000Source | -3,678,000Source |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | 2,000Source | -178,000Source | — |
| Marketable Securities, Unrealized Gain (Loss)USD | 1,000Source | 306,000Source | 1,491,000Source | -1,367,000Source |
| Net Income (Loss) Attributable to ParentUSD | -75,018,000Source | -53,516,000Source | -60,776,000Source | -113,243,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 113,243,000Source |
| Nonoperating Income (Expense)USD | 1,424,000Source | 2,870,000Source | 1,652,000Source | — |
| Operating ExpensesUSD | 65,446,000Source | 46,137,000Source | 55,997,000Source | 110,830,000Source |
| Other Operating Income (Expense), NetUSD | -1,423,000Source | -90,000Source | 1,424,000Source | — |
| Proceeds from Issuance of Common StockUSD | 21,205,000Source | 37,834,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | 163,000Source | 1,670,000Source | 903,000Source | 579,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 13,021,000Source | 11,283,000Source | 9,905,000Source | 8,578,000Source |
| Cost of Goods and Services Sold | —Source | —Source | —Source | —Source |
| Operating Income (Loss)USD | -78,234,000Source | -56,746,000Source | -62,589,000Source | -117,710,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -76,810,000Source | -53,874,000Source | -61,115,000Source | -116,921,000Source |
| Income Tax Expense (Benefit)USD | -1,792,000Source | -358,000Source | -339,000Source | -3,678,000Source |
| Net Income (Loss) Attributable to ParentUSD | -75,018,000Source | -53,516,000Source | -60,776,000Source | -113,243,000Source |
| Earnings Per Share, BasicUSD per share | -1.16Source | -0.91Source | -1.08Source | -2.17Source |
| Earnings Per Share, DilutedUSD per share | -1.16Source | -0.91Source | -1.08Source | -2.17Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 64,790Source | 58,673,000Source | 56,368Source | 52,235Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 64,790Source | 58,673,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 10,508,000Source | 10,612,000Source | 10,612,000Source | 10,607,000Source |
| Current Income Tax Expense (Benefit)USD | 184,000Source | 19,000Source | 38,000Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -153,000Source | 512,000Source | -69,000Source | — |
| Gain (Loss) on InvestmentsUSD | — | 2,000Source | -178,000Source | — |
| General and Administrative ExpenseUSD | 21,587,000Source | 22,455,000Source | 24,272,000Source | 41,254,000Source |
| Goodwill, Impairment LossUSD | — | — | 7,420,000Source | 50,878,000Source |
| Gross ProfitUSD | -12,788,000Source | -10,609,000Source | -6,592,000Source | -6,880,000Source |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | 61,115,000Source | 116,921,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -44,940,000Source | -39,285,000Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -61,115,000Source | — |
| Interest Income (Expense), Nonoperating, NetUSD | 1,424,000Source | 2,870,000Source | 1,652,000Source | 789,000Source |
| Lease IncomeUSD | — | — | 7,000Source | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | 2,000Source | -178,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 113,243,000Source |
| Nonoperating Income (Expense)USD | 1,424,000Source | 2,870,000Source | 1,652,000Source | — |
| Operating ExpensesUSD | 65,446,000Source | 46,137,000Source | 55,997,000Source | 110,830,000Source |
| Other Cost of Operating RevenueUSD | — | — | — | 99,000Source |
| Other ExpensesUSD | 1,253,000Source | 1,043,000Source | 1,024,000Source | 1,251Source |
| Other General and Administrative ExpenseUSD | — | — | — | 12,721,000Source |
| Other IncomeUSD | — | — | 3,000,000Source | — |
| Other Operating IncomeUSD | 18,958,000Source | 90,000Source | — | — |
| Other Operating Income (Expense), NetUSD | -1,423,000Source | -90,000Source | 1,424,000Source | — |
| Research and Development ExpenseUSD | 19,236,000Source | 20,182,000Source | 26,049,000Source | 26,507,000Source |
| Selling and Marketing ExpenseUSD | 5,665,000Source | 3,410,000Source | 4,168,000Source | 4,376,000Source |
Filing attachments
ea030999302ex99-1.htm · 6-K · 2026-10-28
Exhibit 99.1 NANO-X IMAGING LTD The Ofer Tech Park, 94 Shlomo Shmeltzer Road Petach Tikva, Israel 4970602 NOTICE OF SPECIAL GENERAL MEETING OF SHAREHOLDERS To be held on November 18, 2026 Dear Shareholders: We cordially invite you to attend a special general meeting of shareholders of Nano-X Imaging Ltd (“we”, “us”, “Nanox”, “our company”, or the “Company”) to be held at the Company’s offices at The Ofer Tech Park, 94 Shlomo Shmeltzer Road, Petach Tikva, Israel 4970602, on Wednesday, Novem…
Read attachment ↗ea030999302ex99-2.htm · 6-K · 2026-10-28
Exhibit 99.2 NANO-X IMAGING LTD. (THE “COMPANY”) PROXY THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS The undersigned shareholder of Nano-X Imaging Ltd. (the “Company”) hereby nominates, constitute and appoint each of Marina Gofman Feler, Jonathan M. Nathan and Elad Ziv as its true and lawful proxy and attorney with full power of substitution for and in the undersigned’s name, place and stead, to represent and vote all of the ordinary shares, par value NIS 0.01 per share of the Company (…
Read attachment ↗ea030857001ex99-1.htm · 6-K · 2026-10-16
Exhibit 99.1 Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for third Quarter Ended September 30, 2026 PETACH TIKVA, Israel - October 16, 2026 - NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an innovative medical imaging technology company, today provided a brief business update and furnished certain preliminary unaudited financial data for the third quarter ended September 30, 2026. The preliminary figures are estimates based on c…
Read attachment ↗ea030709601ex99-1.htm · 6-K · 2026-09-29
Exhibit 99.1 AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF Nano-x Imaging LTD Dated September 29, 2026 Company Name The name of the Company is Nano-X Imaging Ltd and in Hebrew “ננו-אקס אימג’ינג בע”מ” (the “Company”). Purpose 2.1. The purpose of the Company is to engage in any lawful activity. 2.2. Pursuant to Section 11 of the Companies Law, the Company may from time to time, by decision of the Board of Directors, donate reasonable amounts of…
Read attachment ↗ea030586501ex99-1.htm · 6-K · 2026-09-17
Exhibit 99.1 NANO-X IMAGING LTD The Ofer Tech Park, 94 Shlomo Shmeltzer Road Petach Tikva, Israel 4970602 SUPPLEMENT TO PROXY STATEMENT FOR THE 2026 ANNUAL GENERAL MEETING OF SHAREHOLDERS Originally Scheduled for September 17, 2026 September 17, 2026 This supplement (this “Supplement”) supplements and should be read together with the proxy statement dated August 18, 2026 (the “Proxy Statement”) furnished to shareholders of Nano-X Imaging Ltd (the “Company”) in connection with the Company…
Read attachment ↗ea030482601ex99-1.htm · 6-K · 2026-09-09
Exhibit 99.1 Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates Management to host conference call and webcast on Wednesday, September 9, 2026 at 8:30 AM ET PETACH TIKVA, Israel - September 9, 2026 - NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2026, and provided a business update. Recent Business Highlights: Expanded Nanox…
Read attachment ↗